New Zealand Community Pharmacy Services Agreement

Key Findings: The main themes that emerged were: pharmacists supported the philosophy behind the CPSA, pharmacists` understanding of the CPSA, the implementation of CPSA-related services, the perceived impact on patient outcomes and the future viability of the CPSA. Overall, pharmacists supported the referral of funding to patient-centred services, but pharmacy owners reported difficulties in understanding the funding model, leading to income uncertainties. Many pharmacists felt that the quality of care provided had not changed, while others found that their attitude towards care had changed. All pharmacists reported an increase in their workload and many felt that the sustainability of the CPSA was related to its ability to financially support pharmacies in the community. Methods: A targeted sampling method extracted pharmacists from a matrix, who were then contacted by telephone and invited for questioning. Semi-structured face-to-face interviews were conducted with Community pharmacists (n-17) in urban and rural New Zealand. An interview plan, which examined 12 themes, was used to facilitate discussion and determine the pharmacist`s views and understanding for the CPSA. Interviews were recorded and transcribed literally, and a general inductive approach was adopted to identify emerging topics. THE PHARMAC announces changes to the rules for the distribution of frequencies, in accordance with the new pharmacy services, to support compliance and respect for medicines for patients. Under the previous model, pharmacies were paid for the amount of drugs dispensed. The resulting growth in pharmacy spending has become unsustainable and the link between funding and volume costs has been unsustainable with patient outcomes. In 2009/2010, the total cost of the tax was $320 million, of which $82 million was spent on the Close Control Pharmaceutical Schedule Rule (now known as dispensing Frequency). Of the $82 million spent on Close Control, more than half ($46 million) was spent on the weekly tax.

The new funding model will focus on patients and allow pharmacists to better ensure that drugs are respected and respected, especially for patients with multiple comorbidity and for the use of many medications.